Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, and Immunotherapy and Immune Responses.
Extrachromosomal DNA–Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma
Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies
1909P Radiological and molecular patterns of metastatic growth in lung cancer within TRACERx
Embracing cancer complexity: Hallmarks of systemic disease
Origins and impact of extrachromosomal DNA
Why do patients with cancer die?
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
Research autopsy programmes in oncology: shared experience from 14 centres across the world
Abstract PR011: Comprehensive longitudinal tracking of lung cancer evolutionary clonal dynamics during therapy using circulating tumour DNA
LBA9 Clinical insights from ultra-sensitive tumour-informed ctDNA tracking across the TRACERx cohort
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
Cachexia: A systemic consequence of progressive, unresolved disease
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
Targeted profiling of human extrachromosomal DNA by CRISPR-CATCH
Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution
Pervasive chromosomal instability and karyotype order in tumour evolution
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Scalable and robust SARS-CoV-2 testing in an academic center
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
Neoantigen-directed immune escape in lung cancer evolution
A clonal expression biomarker associates with lung cancer mortality
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Tracking the Evolution of Non–Small-Cell Lung Cancer
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution